Although the accumulation of a monoclonal population of CD5+/CD19+ B cells is characteristic of both prognostic groups, aggressive CLL appears to have some distinct characteristics and signaling properties compared to indolent CLL [2]. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.